Target intelligence / Profile preview

Solute carrier family 35 member G5 (SLC35G5)

Target
SLC35G5
Molecular classification
Transporter, SLC family member, Nucleotide sugar transporter (putative, SLC35 family), Multi-pass membrane protein (predicted)
01

Overview

Solute carrier family 35 member G5 (SLC35G5) is a protein encoded by the SLC35G5 gene in humans[1][2][6][7]. SLC35G5 is predicted to be a multi-pass membrane transporter belonging to the SLC35 family, which primarily includes nucleotide sugar transporters[3]. It is expressed in placenta and testis[1]. The exact physiological substrate and function are uncharacterized, and it is not currently considered a therapeutic target, nor are there known disease associations or drug interactions[1][3][7]. Alternative names include AMAC1L2 and acyl-malonyl-condensing enzyme 1-like protein 2, based on sequence similarity, but these aliases do not denote established catalytic function[1][6]. No data supports involvement in major biological signaling, enzyme activity, or clinical pharmacology. If more functional/structural details become available (such as substrate specificity, transport mechanism, or disease linkage), the target may be reclassified. Current information supports its designation as an uncharacterized SLC family member, likely involved in nucleotide-sugar transport, but not yet confirmed as a therapeutic target.

Other names
AMACAMAC1L2Acyl-malonyl-condensing enzyme 1-like protein 2Acyl-malonyl condensing enzyme 1-like 2protein AMAC1L2solute carrier family 35, member G5SLC35G5
02

Biological functions

Other (uncharacterized; predicted to be involved in transmembrane transport of nucleotide-sugars, given SLC35 family classification)
03

Disease associations

Other (no direct association with well-characterized disease roles; listed in connection with Keratolytic Winter Erythema and Lateral Sinus Thrombosis, but no mechanistic link established)

Beyond the preview

Go deeper on Solute carrier family 35 member G5 (SLC35G5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 35 member G5 (SLC35G5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call